Cme (CME) Common Equity (2009 - 2026)

Cme (CME) has 18 years of Common Equity data on file, last reported at $26.6 billion in Q1 2026.

• Common Equity for Q1 2026 came in at $26.6 billion, up 468.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.6 billion (up 468.05% YoY), and the FY2025 annual result was $28.7 billion, up 8.46% from the prior year.
• Common Equity retreated to $26.6 billion in Q1 2026 per CME's latest filing, from $28.7 billion in the prior quarter.
• Over five years, Common Equity peaked at $28.7 billion in Q4 2025 and troughed at -$95.0 million in Q2 2024.
• A 5-year average of $12.2 billion and a median of $5.3 billion in 2025 frame the typical range for Common Equity.
• The sharpest annual moves came in 2024 and 2025: Common Equity sank 4220.0% in 2024, then jumped 65355.32% in 2025.
• A 5-year view of Common Equity shows it stood at -$900000.0 in 2022, then jumped by 6988.89% to $62.0 million in 2023, then surged by 42620.81% to $26.5 billion in 2024, then grew by 8.46% to $28.7 billion in 2025, then declined by 7.34% to $26.6 billion in 2026.
• Business Quant data shows CME's Common Equity at $26.6 billion in Q1 2026, $28.7 billion in Q4 2025, and $28.2 billion in Q3 2025.